Clinical Trial Update: Efficacy of AIN457 in Adults (18-65 Years) With Psoriatic Arthritis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the efficacy of AIN457 in adults with psoriatic arthritis has completed and results were posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriatic Arthritis

Drugs mentioned

• AIN457

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Psoriatic Arthritis | Phase 2 | Status: COMPLETED | Results posted: 2015-11-13